The Value of Addition of Human Menopausal Gonadotropin Drug Following Oocytes Retrieval in IVF Cycles
Status:
Recruiting
Trial end date:
2022-08-15
Target enrollment:
Participant gender:
Summary
The aim of this study is to test the hypothesis that addition of daily small dose of human
menopausal gonadotropin (HMG) drug following oocytes retrieval could improve the fertility
outcome in women undergoing in-vitro fertilization